-
Is the new higher-dose Wegovy safe?
The MHRA has approved a 7.2mg dose of Wegovy, which has shown promising results in clinical trials. However, experts warn that higher doses may carry increased risks of side effects. Safety depends on individual health conditions, and ongoing medical supervision is essential when using higher doses of weight loss medications.
-
Can I lose 20% of my weight with the new drug?
Trials indicate that Wegovy at the higher dose can lead to over 20% weight loss in some users. While this is significant, results vary based on individual factors like diet, exercise, and adherence to treatment. Always consult a healthcare professional to determine if this medication is suitable for your weight loss goals.
-
What are the long-term risks of weight loss meds like Wegovy?
Long-term use of weight loss medications raises concerns about nutritional deficiencies, especially since up to 40% of weight lost can be lean body mass. Additionally, there are worries about potential side effects, dependency, and the body's response after stopping treatment. Ongoing research is needed to fully understand these risks.
-
Why do people regain weight after stopping treatment?
Many users experience rapid weight regain within 20 months after stopping drugs like Wegovy. This is because obesity is a chronic condition that requires ongoing support, behavioral changes, and environmental adjustments. Medication alone isn't enough for sustained weight management.
-
Are there systemic barriers to long-term weight management?
Yes, in the UK, NHS caps on GLP-1 prescriptions and high private treatment costs limit access to these medications. This makes it difficult for many to maintain long-term treatment, emphasizing the need for comprehensive approaches that include lifestyle and environmental changes.